ResearchRSSYesterday
A study in Japan found that Hemlibra, a medicine used to treat acquired hemophilia A (a rare bleeding disorder that develops later in life), appears to be safe when used alongside other medications that suppress the immune system. Acquired hemophilia A is different from the hemophilia people are born with—it happens when the body mistakenly attacks its own clotting proteins. This is the first real-world evidence supporting Hemlibra's safety for this condition in actual patients.
WHY IT MATTERSIf you have acquired hemophilia A in Japan or are considering treatment options, this study suggests Hemlibra may be a safe addition to your treatment plan, though you should discuss this with your hematologist to see if it's right for your specific situation.
AdvocacyRSS3 days ago
A mother shares her personal story about raising two sons with severe hemophilia A, a bleeding disorder where the blood doesn't clot properly. She describes how she has had to stay strong and vigilant while caring for her children and managing the challenges that come with this lifelong condition.
WHY IT MATTERSPersonal stories from hemophilia caregivers help newly diagnosed families understand what to expect and show that others have navigated similar challenges successfully.
Drug approvalRSS4 days ago
Hympavzi is a new injection medicine approved in 2024 to help prevent bleeding in people with hemophilia. In the large study that led to its approval, the medicine worked well at stopping bleeds before they happened. When breakthrough bleeds did occur, doctors were able to treat them successfully using standard blood clotting medicines.
WHY IT MATTERSIf you have hemophilia, this news shows that Hympavzi can reduce bleeding episodes while still allowing doctors to treat any bleeds that do happen with familiar, proven treatments—meaning you don't have to choose between prevention and effective emergency care.
NewsRSS4 days ago
A person with hemophilia shares their experience deciding when and how to tell others about their condition. They describe how managing hemophilia—a bleeding disorder that requires regular factor VIII infusions every 48 hours—affects their daily life and social interactions. The article explores the personal challenge of balancing privacy with the need to explain absences or limitations caused by their treatment.
WHY IT MATTERSPeople with hemophilia often struggle with disclosure decisions that affect work, relationships, and social participation, and hearing from others navigating these choices can help patients develop their own communication strategies.
NewsRSS5 days ago
People with hemophilia need to work with their doctors to choose the best treatment plan. There are two main types of treatment: preventive medicine taken regularly to stop bleeding before it starts, and medicine taken only when bleeding happens. The right choice depends on each person's specific situation and needs.
WHY IT MATTERSUnderstanding prophylaxis versus on-demand treatment helps hemophilia patients and caregivers make informed decisions about which approach may reduce bleeding episodes and improve quality of life.
NewsRSS5 days ago
People with hemophilia experience pain that lasts long after bleeding episodes are treated. Joint damage from repeated bleeds can cause ongoing discomfort that affects daily life and quality of life. A patient named Thomas Graham shares his experience with how this lingering pain impacts his ability to do everyday activities.
WHY IT MATTERSMany hemophilia patients focus on stopping acute bleeds but don't realize that chronic pain and joint damage from past bleeds can significantly limit their quality of life even when bleeding is controlled.
AdvocacyRSS5 days ago
Thomas Graham shares his personal story about fighting with insurance companies to get the hemophilia treatment he needs. The article explains the barriers patients face when trying to access care and emphasizes that patients need to speak up for themselves. Insurance denials and delays are common problems for people with hemophilia, and knowing how to advocate can make a real difference.
WHY IT MATTERSHemophilia patients often face insurance denials or delays for clotting factor treatments, and learning advocacy strategies from patient experiences can help others navigate these barriers more effectively.
NewsRSS5 days ago
Hemophilia treatments work differently in different people's bodies. A doctor named G Shellye Horowitz explains that asking your doctor for pharmacokinetic testing can help make sure your hemophilia medicine is working the best way for your specific body. This test measures how your body processes the medication so doctors can adjust your dose if needed.
WHY IT MATTERSPharmacokinetic testing can personalize your hemophilia treatment plan, potentially improving how well your therapy controls bleeding and reducing the need for frequent dose adjustments.